Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Electrocardiographic Data From High-risk Cardiac Patients Using Willem™ Cardiologist-level Artificial Intelligence Software. WILLEM Trial.

NCT05890716 is registered in ClinicalTrials.gov with Idoven 1903 S.L. as lead sponsor.

NCT NCT05890716
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05890716 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Electrocardiographic Data From High-risk Cardiac Patients Using Willem™ Cardiologist-level Artificial Intelligence Software. WILLEM Trial.
Lead sponsor
Idoven 1903 S.L.
Phase
Observational
Overall status
Recruiting
Start date
April 4, 2023
Completion date
November 30, 2026
Enrollment
5,342 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac arrest, cardiac arrhythmias, cardiomyopathies, sudden cardiac death